The morphological differentiation of Parkinson disease with dementia (PDD) and dementia with Lewy bodies (DLB) is a matter of discussion. The objective of this study was to investigate the regional distribution of beta-amyloid (Abeta) plaques, alpha-synuclein (AS), and pathology in both disorders...
The pathophysiological mechanisms of cognitive dysfunction and dementia in Parkinson's disease (PD) are still poorly understood. Altered resting state oscillatory brain activity may reflect underlying neuropathological changes. The present study using magneto encephalography (MEG) was set up to study ...
"These results are very encouraging for people with Parkinson's and their families that they can take advantage of the benefits of deep brain stimulation without worrying about it increasing the likelihood of developing dementia," said study author Elena Moro, MD, of Grenoble Alpes University in G...
We reviewed the histories of patients seen in a large Parkinson's disease clinic from 1983 to 1989 to determine if there is a relationship between the timing of initiation of levodopa therapy and the development of motor response fluctuations, dyskinesias, and dementia. There were no factors pred...
Meds for Parkinson’s disease Steroids Estrogen Arthritis drugs Should a senior show signs of depression when using specific medications, consult with the doctor about switching to another one or reducing the dosage. Ask about side effects with any new medications, even those purchased over the ...
doi:10.1016/S1353-8020(11)70189-4I.-U. Song and Y.-D. Kim and K.-S. LeeParkinsonism & Related Disorders
Does motor subtype influence neurocognitive performance in Parkinson's disease disease without dementia? Eur J Neurol 2008; 15: 262-7.Lyros E, Messinis L, Papathanasopoulos P (2008) Does motor subtype influence neurocognitive performance in Parkinson’s disease without dementia? Eur J Neurol 15:...
doi:10.1016/s1353-8020(11)70189-4I.-U. SongY.-D. KimK.-S. LeeElsevier BV